CMIC Group

Overview

CMIC Group, established in 1985 and headquartered in Japan, operates within the manufacturing sector, specifically focusing on pharmaceuticals. With a workforce of between 5,001 and 10,000 employees, the company reported significant revenue of approximately $2.6 billion. CMIC Group addresses the challenges associated with rare diseases, which are defined as conditions affecting a small number of patients, often complicating drug development due to limited market potential and insufficient research. The company highlights the existence of 6,000 to 8,000 types of rare diseases worldwide, impacting around 350 million individuals. To tackle these challenges, CMIC Group established OrphanPacific in 2012, aimed at facilitating the development and delivery of orphan drugs in Japan. Their efforts are directed towards improving patient outcomes by addressing the high medical needs associated with these difficult-to-treat conditions. The company also emphasizes the importance of raising social awareness regarding rare diseases and the complexities involved in their treatment and management, as evidenced in their technical reports on healthcare and social challenges.

Industry